Pennsylvania HR 575: A Resolution designating the month of November 2019 as "Commonwealth Hunters Recognition Month" in Pennsylvania.

Bill Text

PRINTER'S NO. 3658
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE RESOLUTION
No. 575
Session of
2026
INTRODUCED BY McNEILL, TIBURCIO, RIVERA, HARKINS, McANDREW,
MERSKI, DOUGHERTY, VENKAT, ANDERSON, HOWARD, GALLAGHER,
JAMES, DEASY, DIAMOND, CONKLIN, HOHENSTEIN AND SANCHEZ,
JUNE 18, 2026
REFERRED TO COMMITTEE ON HEALTH, JUNE 22, 2026
A RESOLUTION
Designating the month of September 2026 as "Prostate Cancer
Awareness Month" in Pennsylvania.
WHEREAS, The prostate is a small gland found only in men and
located below the bladder; and
WHEREAS, In some cases, prostate cancer can make the prostate
enlarged; and
WHEREAS, Prostate Cancer Research, a nonprofit organization
under the National Cancer Research Institute, reports that the
risk of prostate cancer increases with age with most cases
diagnosed in men over 50 years of age; and
WHEREAS, According to the Prostate Conditions Education
Council, 1 in 8 American men will get prostate cancer and 1 in
41 men will die from prostate cancer; and
WHEREAS, The American Cancer Society estimated that more than
13,000 new cases of prostate cancer will have been diagnosed in
2025 in Pennsylvania; and
WHEREAS, The American Cancer Society estimated that 1,500
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17

Pennsylvanians will have died of prostate cancer in 2025; and
WHEREAS, The Centers for Disease Control and Prevention
describes symptoms of prostate cancer that include difficulty
starting urination, weak or interrupted flow of urine, trouble
emptying the bladder completely, pain or burning during
urination, blood in the urine and pain in the back, hips or
pelvis; and
WHEREAS, Prostate cancer can be dormant in a person's body
for up to 20 years without symptoms, increasing the chance that
a person may be sick without the person's knowledge; and
WHEREAS, The American Cancer Society recommends that men with
an average risk of prostate cancer consult with their health
care provider about whether to be screened for prostate cancer
at 50 years of age; and
WHEREAS, For men at a high risk of developing prostate cancer
and men who have a first-degree relative diagnosed with prostate
cancer at an early age, consultations with a health care
provider should begin at 45 years of age; and
WHEREAS, For men at even greater risk, including those with
more than one first-degree relative who had prostate cancer at
an early age, screening should begin at 40 years of age; and
WHEREAS, Men should consult with their physician about the
benefits of screening for prostate cancer; and
WHEREAS, There are two tests used by physicians to screen for
prostate cancer: a prostate-specific antigen test, which
measures the level of prostate-specific antigen in the blood,
and a digital rectal examination, which detects abnormalities of
the prostate; and
WHEREAS, If abnormalities are noted from either screening, a
biopsy may be recommended to assist in diagnosing potential
20260HR0575PN3658 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30

prostate cancer; therefore be it
RESOLVED, That the House of Representatives designate the
month of September 2026 as "Prostate Cancer Awareness Month" in
Pennsylvania.
20260HR0575PN3658 - 3 -
1
2
3
4